Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - Scil Technology GmbH

September 14, 2009
Scil Proteins acquires Tat Phage display from ipal GmbH and Charité, Berlin
Deal enhances Scil Proteins’ Affilin discovery engine. More

January 16, 2008
Pfizer and Scil finalize agreement for novel cartilage growth factor
Pfizer Inc and Scil Technology GmbH have signed a licensing agreement for worldwide collaboration on Scil’s cartilage specific growth factor CD-RAP. More

October 10, 2005
Scil Technology acquires rights to worldwide patents for CD-RAP from Roche Diagnostics GmbH
Scil Technology, a biopharmaceutical company focused on the development of dental and orthopaedic tissue regeneration products, today announced that it had acquired the worldwide patents and patent applications concerning the substance and production of the growth factor MIA/CD-RAP from Roche Diagnostics GmbH. More

June 21, 2005
Scil Technology Announces Positive Results in Preclinical Proof-of-Concept Study in Spinal Fusion
MARTINSRIED, Germany, June 21, 2005 – Scil Technology, a biopharmaceutical company focused on the development of dental and orthopaedic tissue regeneration products, today announced that a proof-of-concept study for its lead orthopaedic product, ST01, has revealed superior efficacy to autologous bone in an in vivo preclinical study for posterolateral interbody spinal fusion. Autologous bone is the current gold standard in spinal fusion surgery. More

June 9, 2005
Scil Technology Announces Positive Results in Preclinical Study of its Lead Dental Bone Augmentation
MARTINSRIED, Germany, June 9, 2005 – Scil Technology, a biopharmaceutical company focused on the development of dental and orthopaedic tissue regeneration products, today announced that it has successfully concluded preclinical studies with its lead regenerative dental bone augmentation material, MD05. More

December 9, 2004
Scil Technology Receives Renewal of GMP Certification for its analytical and Bioassay Laboratories
MARTINSRIED, Germany, December 9, 2004 – Scil Technology, a biopharmaceutical company focused on the development of dental and orthopaedic tissue regeneration products, today announced that it has received notification of a renewal of its GMP certification from the German health authorities. More

December 1, 2004
Scil Technology Initiates Research into Cartilage Repair Using a Cartilage-Specific Growth Factor
MARTINSRIED, Germany, December 1, 2004 – Scil Technology, a biopharmaceutical company focused on the development of dental and orthopaedic tissue regeneration technologies, today announced that it has commenced research into the development of cartilage repair products using a cartilage specific growth factor. More

November 18, 2004
Scil Technology Initiates Preclinical Proof of Concept Study for Orthopaedic Project in Spinal Fusio
MARTINSRIED, Germany, November 18, 2004 – Scil Technology, a biopharmaceutical company focused on the development of dental and orthopaedic tissue regeneration products, today announced that it has initiated its first preclinical proof-of-concept study for its lead orthopaedic project in spinal fusion, ST01. More

May 5, 2004
Scil Technology Files Patent on Coating Technology for Implants
MARTINSRIED, Germany, May 5, 2004 – Scil Technology, a biopharmaceutical company focused on the development of dental tissue regeneration products, today announced it has extended its IP portfolio by a further patent application. More

October 28, 2003
Scil Technology – a New German Biopharmaceutical Company – is Launched by the Scil Group
MARTINSRIED, Germany, October 28, 2003 – Scil Technology, a new company focused on the development of tissue regeneration products, was officially launched today. The Company was created from the Scil Group and has one shareholder, BioNet Holding GmbH. At the same time, Scil Technology announced that it has appointed Dr Irina Staatz-Granzer as Managing Director of the new Company.
More

Data


25,983
Tech investments
From our Online Data Service
16,806
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Aug 12€2.4MBusiness applications
Aug 12€0.7MMedical devices
Aug 12N/AMedical devices
Aug 9€7.0MSoftware development
Aug 9€0.3MeLearning
Aug 9N/AOther Biotechnology & Healthcare
Aug 7€3.8MDiagnostics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.